The results have been described as a “major breakthrough”. (Representative)
LONDON:
Giving low doses of the generic dexamethasone steroid to patients admitted to hospital with COVID-19 has reduced death rates by about a third among those with the most serious infections, data showed on Tuesday. test.
The results, described as a “major breakthrough” by scientists conducting the UK-led clinical trial known as RECOVERY, suggest that the drug should immediately become standard care in patients treated in hospital with the pandemic, the researchers said.
“This is a result that shows that if patients who have COVID-19 and are on respirators or are on oxygen receive dexamethasone, it will save lives, and it will do so at a remarkably low cost,” said Martin Landray, an Oxford University Professor who co-directs the essay.
Its lead co-investigator, Peter Horby, said that dexamethasone – a generic steroid widely used in other diseases to reduce inflammation – is “the only drug that has so far shown to reduce mortality – and it significantly reduces it. “
“It is a major breakthrough,” he said.
There is currently no approved treatment or vaccine for COVID-19, the disease caused by the new coronavirus that has killed more than 431,000 people worldwide.
(With the exception of the title, this story was not edited by GalacticGaming staff and is published from a syndicated feed.)
